KitoTech Medical is a medical device company based in Seattle, WA, that developed and commercialized microMend, a patented wound-closure product consisting of miniature stainless steel staples on an adhesive backing. microMend is designed to combine the holding strength of a suture with the simplicity of applying a bandage for closing lacerations, skin tears, surgical incisions and other wounds. The company plans to use proceeds to increase commercial efforts in the medical market, expand consumer sales channels, build a medical sales organization, and introduce products into specialties such as orthopedics, obstetrics and gynecology, and surgery. KitoTech is led by President and CEO Dr. Ronald Berenson. Financially, the company reported a first close of approximately $2M of its Series B round, with the potential to raise a total of $6M. The fundraising is intended to drive greater adoption of the microMend family among physicians, hospitals and clinics. KitoTech Medical develops and sells microMend, an array of miniature stainless steel staples attached to an adhesive backing that combines the holding strength of sutures with the simplicity of a bandage. The company was spun out of the University of Washington and uses a patented Microstaple Technology platform to address wound closure and wound care. KitoTech markets microMend for lacerations, skin tears, surgical incisions, and other wounds, and also offers consumer products for at-home use. Recent activity shows rapid sales growth in the consumer market since introducing microMend products to that segment a few months ago. The company plans to expand its commercial organization to sell to more physicians, hospitals, and clinics and to enter additional clinical specialties including orthopedics, obstetrics and gynecology, and general surgery. KitoTech Medical develops microstaple wound-closure devices based on technology originally from the University of Washington, most notably the microMend. microMend is currently on the market, is being sold, and is undergoing clinical trials; the company says it can heal wounds up to three times faster than traditional sutures. The device uses tiny staples that poke into skin on either side of a wound and hold tissue together with tension from a small spring; it is painless to apply and removable by patients, and can be applied by non‑clinicians like a butterfly bandage. KitoTech is also developing wound dressings and artificial skin and believes the microstaple technology can attach items such as colostomy bags, surgical drains, and glucose monitors to skin. Its products are being used by primary and urgent care clinics, schools, athletic programs, emergency services and the military, and Henry Schein recently began carrying microMend. The company was founded in 2012, is based in Seattle’s South Lake Union neighborhood, has six employees, and is led by CEO Ron Berenson. KitoTech Medical is an early-stage medical device company based in Seattle. The article identifies the company only by sector (medical devices) and location; no product details or founding year are provided. Its current financing situation includes a $500,000 investment from a new joint venture between Rezon8 Capital & Advisory Group and the Harvard‑Stanford Collaborative Alumni Angels Group of Washington, DC (CAAGDC). The backing is described as growth funding/co-investment to support the company’s early-stage development. Investors say they will provide business connections, strategic and operational expertise to help accelerate growth. The joint group indicated it can act as a lead investor in certain funding situations.

Total raised

$9M

Funding rounds

4

Latest round

Series B

Latest activity

Dec 2021